This report outlines a strategy for management of human resources for TB control.
These guidelines have been developed to assist national TB control programs (NTPs) in adopting specific anti-TB drug resistance surveillance systems to measure susceptibility to first-line TB drugs.
This book provides guidelines to national TB program managers, policy makers, nongovernmental organizations, and donor agencies on effective management of TB. The guidelines focus on the technical and managerial aspects of treatment.
This guideline sets forth the framework to guide European countries in developing their national plan for reducing TB/HIV morbidity and mortality. The framework sets out the rationale for effective collaboration between HIV/AIDS and tuberculosis national programs.
This resource presents a method of assessing and updating laboratory procedures to assist in detecting TB early by reducing lab turnaround time for reporting positive smear, culture, identification, and susceptibility results.
This report presents a regional framework for addressing TB/HIV co-infection in the Western Pacific that is adapted to the epidemiological profile and health service system of the region and identifies areas in which both programs can complement each other to address TB/HIV.
This guideline promotes collaboration between TB and HIV/AIDS programs to reduce the burden for people affected by both diseases.
This poster serves as a quick reference to the Revised Treatment of Tuberculosis Guidelines published in February 2003 by the American Thoracic Society, CDC, and the Infectious Disease Society of America. It contains information on treatment during the initial and continuation dosing phases, the...
This book is for health care workers considering embarking on TB control in prisons and covers structural, administrative, and medical issues. It is designed primarily for use in settings where there is a high incidence of TB and limited resources.
This report presents information about the Global TB Drug Facility, a program designed to ensure access to and the availability of TB drugs.